Skip to content
sellModerate cluster of 4

Deepika Jalota sold $35k of PMVP

Chief Development Officer at PMV Pharmaceuticals, Inc.. 33,065 shares at an average of $1.06, traded Jul 1, 2025, filed Jul 3, 2025.

Warning score
46
Value
$35k
33,065 shares
Holdings after
89,959
-27% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $35k at market
    +6
  • Share of holdings sold
    Sold 27% of holdings
    +10
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-25-019384, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2025SOpen-market sale
Common Stock
-33,065$1.06$35k89,959Jul 3, 2025

Related signals

Other insiders at PMV Pharmaceuticals, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
36Weak
PMVPsell
PMV Pharmaceuticals, Inc.
Orbimed Advisors LLC
owner
$900k
500,000 shares
-8%
52Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
Michael Carulli
Chief Financial Officer
$30k
28,249 shares
-32%
47Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
David Henry Mack
President and CEO
$62k
58,411 shares
-10%
40Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
Robert Ticktin
General Counsel & COO
$25k
23,151 shares
-19%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Deepika Jalota sold $35k of PMVP | InsiderTell